Transitioning from Insulin Infusion to Oral Medications in DKA Management

Criteria for DKA Resolution Before Transition

The American Diabetes Association recommends transition from IV insulin infusion when blood glucose is less than 200 mg/dL, serum bicarbonate is ≥18 mEq/L, venous pH is >7.3, anion gap is normalized (≤12 mEq/L), and patient is clinically improved and able to tolerate oral intake 1
The American College of Clinical Endocrinologists suggests that anion gap should be normalized (≤12 mEq/L) before transitioning from IV insulin infusion 2

The Endocrine Society recommends administering subcutaneous basal insulin 2-4 hours before stopping the IV insulin infusion to prevent rebound hyperglycemia 1
The American Association of Clinical Endocrinologists suggests continuing IV insulin for 1-2 hours after administering subcutaneous insulin to ensure adequate plasma insulin levels 1

The European Association for the Study of Diabetes recommends initiating oral antidiabetic medications only after complete resolution of DKA, patient is hemodynamically stable, patient is able to eat and drink normally, and transition to subcutaneous insulin has been successfully completed 3, 4
The American Diabetes Association suggests that for patients with newly diagnosed diabetes, oral medications should not be started until after 24-48 hours of metabolic stability on subcutaneous insulin 3, 6

The International Diabetes Federation recommends DPP-4 inhibitors as the preferred initial oral agent for patients with moderate hyperglycemia (BG 201-300 mg/dL) 3, 4, 6
The American College of Cardiology suggests considering adding basal insulin (0.2-0.3 U/kg/day) with the oral agent 3, 6

The American Association of Clinical Endocrinologists recommends checking blood glucose every 2-4 hours while NPO, and continuing monitoring until the patient is eating with stable glucose levels 1
The Endocrine Society suggests monitoring electrolytes, especially potassium, as insulin therapy can cause hypokalemia 1, 2

The European Association for the Study of Diabetes warns that abrupt discontinuation of IV insulin without overlapping with subcutaneous insulin can lead to rebound hyperglycemia 1
The American Diabetes Association advises against starting oral medications too early before complete resolution of ketoacidosis, as it can lead to treatment failure 3, 4